Publication | Closed Access
Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertension in vivo
90
Citations
33
References
2013
Year
We identified RXFP1 as a potential new therapeutic target for PHT and MF activation status.
| Year | Citations | |
|---|---|---|
Page 1
Page 1